Real-life efficacy of guselkumab in patients with early psoriatic arthritis.

Ilenia PantanoDaniele MauroFrancesca RomanoAlessio GambardellaMario ValentiDavide SimoneDaniela IaconoAntonio CostanzoGiuseppe ArgenzianoFrancesco Ciccia

Published in: Rheumatology (Oxford, England) (2021)

Real-life data on a cohort of early PsA patients confirm the efficacy and safety of Guselkumab on peripheral and axial manifestations.

Keyphrases

end stage renal disease
prostate cancer
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
electronic health record
machine learning
big data
artificial intelligence